Epidermal growth factor receptor mutations: association with favorable local tumor control following Gamma Knife radiosurgery in patients with non–small cell lung cancer and brain metastases

Cheng‐Chia Lee, Sanford P.c. Hsu, Chung‐Jung Lin, Hsiu‐Mei Wu, Yuwei Chen, Yung‐Hung Luo, Chi‐Lu Chiang, Yong-Sin Hu, Wen‐Yuh Chung, Cheng‐Ying Shiau, Wan‐Yuo Guo, David Hung‐Chi Pan, Huai‐Che YangJournal of Neurosurgery 2019 · DOI

Abstract

The current study demonstrated that, among patients with NSCLC-BMs, EGFR mutations were independent prognostic factors of tumor control. It was also determined that a combination of GKRS and TKI had the most pronounced effect on prolonging survival after SRS. In select patient groups, treatment with SRS in conjunction with EGFR-TKIs provided effective tumor control for NSCLC-BMs.
BibTeX
@article{lee2019epidermal,
  author = {Cheng‐Chia Lee and Sanford P.C. Hsu and Chung‐Jung Lin and Hsiu‐Mei Wu and Yuwei Chen and Yung‐Hung Luo and Chi‐Lu Chiang and Yong-Sin Hu and Wen‐Yuh Chung and Cheng‐Ying Shiau and Wan‐Yuo Guo and David Hung‐Chi Pan and Huai‐Che Yang},
  title = {{Epidermal growth factor receptor mutations: association with favorable local tumor control following Gamma Knife radiosurgery in patients with non–small cell lung cancer and brain metastases}},
  journal = {Journal of Neurosurgery},
  year = {2019},
  doi = {10.3171/2019.4.jns19446},
}

Loading related content...

Figure